Irish start-up MDI Plus has announced the availability of its novel metered dose inhaler carton, which can be used as a spacer. The carton/spacer includes holes in each end of the cardboard box, with an opening on one end shaped to accommodate the inhaler mouthpiece and an opening on the other end for inhalation. According to the company's web site, the carton can be … [Read more...] about MDI Plus launches MDI carton that doubles as a spacer
Products and Services
Oz-UK adds manufacturing line for MDIs with LGWP propellants
CRO Oz-UK has announced that it is installing a new manufacturing line for metered dose inhalers that use LGWP propellants and expects the new line to be in operation by July 2024. According to the company, the line will be able to handle both HFO-1234ze and HFA-152a solution and suspension formulations, with batch sizes of 2.5 to 10 kg. In addition to a recent … [Read more...] about Oz-UK adds manufacturing line for MDIs with LGWP propellants
Aptar Pharma opens new manufacturing facility in Mumbai
Aptar Pharma has announced the official opening of its new 7,000 sq m manufacturing facility in Mumbai, India. Aptar has been manufacturing MDI valves and pumps at the site since 2012. According to Aptar, the capabilities there "have now been expanded to offer more innovative product solutions and ensure increased manufacturing capacity to pharma customers in South … [Read more...] about Aptar Pharma opens new manufacturing facility in Mumbai
Recipharm announces appointment of Simon Gardner as Business Development Specialist, partnership with Oz-UK on LGWP MDIs
CDMO Recipharm announced that it has hired former Koura Global Business Development Director Simon Gardner as Business Development Specialist for pMDIs to assist customers with the transition to LGWP propellants. Recipharm President, Advanced Delivery Systems, Chris Hirst commented, "Vital to a successful transition for our customers is having access to a team of … [Read more...] about Recipharm announces appointment of Simon Gardner as Business Development Specialist, partnership with Oz-UK on LGWP MDIs
Kindeva and Koura partner on conversion of existing MDI to HFA 152a
Kindeva Drug Delivery and Koura Global parent company Orbia Advance Corporation announced that they have partnered to convert a currently marketed metered dose inhaler to use Koura's HFA 152a (Zephex 152a), a lower global warming potential (LGWP) propellant. According to the announcement, the collaboration "aims to facilitate conversion of pMDI products to the … [Read more...] about Kindeva and Koura partner on conversion of existing MDI to HFA 152a
FDA contracts with Aptar for LGWP propellant study
Aptar said that the company has won a contract worth up to $6 million from the FDA for a study "designed to provide the FDA with information related to the formulation, manufacture, device design and quality aspects related to low-GWP propellant MDIs and their utility to replace existing propellant MDIs." According to Aptar, the study is part of the FDA's development … [Read more...] about FDA contracts with Aptar for LGWP propellant study
1nhaler raises £2 million for development of its single-use cardboard DPI
Scottish device company 1nhaler has raised £2 million for development of a credit-card sized dry powder inhaler in a funding round led by Archangels, the investment firm announced. The 1nhaler device is made out of cardboard, contains a single dose of carrier-free API deposited on a membrane, and is breath-activated. According to the announcement, 1nhaler was … [Read more...] about 1nhaler raises £2 million for development of its single-use cardboard DPI
Hovione partners with IDC on new intranasal dry powder delivery devices
CDMO Hovione has announced a partnership with Industrial Design Consultancy (IDC) for development of two new devices for intranasal delivery of dry powder formulations. According to the announcement, the capsule-based single-use and multidose devices will be available exclusively in conjunction with Hovione's nasal drug development and manufacturing services. … [Read more...] about Hovione partners with IDC on new intranasal dry powder delivery devices
Silo Pharma licenses Medspray’s soft mist technology for delivery of SPC-15 intranasal ketamine
Silo Pharma announced that it has signed a license agreement with Medspray Pharma for the use of Medspray's soft mist spray technology for delivery of Silo’s SPC-15 intranasal ketamine. According to Silo, the Medspray technology delivers "A formulation-specific, customized aerosol plume that is designed to allow for better deposition in the relevant region of the … [Read more...] about Silo Pharma licenses Medspray’s soft mist technology for delivery of SPC-15 intranasal ketamine
Ab Initio Pharma opens new R&D facility
Australian CDMO Ab Initio Pharma has announced the opening of a new R&D facility in Sydney, which the company says is "fitted out to provide state-of-the-art testing and R&D services to Australian and overseas companies developing innovative therapeutics." Ab Initio also has a GMP manufacturing facility that was granted a license by the TGA in 2022 to … [Read more...] about Ab Initio Pharma opens new R&D facility